Antibiotic prophylaxis for wound infections in total joint arthroplasty : A systematic review

Journal of Bone and Joint Surgery - Series B

Volumn 90, Issue 7, 2008, Pages 915-919

  AlBuhairn, B ^a   Hind, D ^a,c   Hutchinson, A ^a,b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b Department of Family Studies and Human Development

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEPHALOSPORIN; CEPHALOSPORIN DERIVATIVE; FIRST GENERATION CEPHALOSPORIN; PENICILLIN DERIVATIVE; POLYPEPTIDE ANTIBIOTIC AGENT; SECOND GENERATION CEPHALOSPORIN;

ANTIBIOTIC PROPHYLAXIS; CLINICAL TRIAL; HIP ARTHROPLASTY; HUMAN; INFECTION RISK; METHODOLOGY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK FACTOR; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW; TOTAL KNEE REPLACEMENT; WOUND INFECTION;

ANTIBIOTIC PROPHYLAXIS; ARTHROPLASTY; EVIDENCE-BASED MEDICINE; HUMANS; ORTHOPEDIC PROCEDURES; PROSTHESIS-RELATED INFECTIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STAPHYLOCOCCAL INFECTIONS;

EID: 47549097730     PISSN: 0301620X     EISSN: None     Source Type: Journal    
DOI: 10.1302/0301-620X.90B7.20498     Document Type: Review

References (58)

1. Nehrer S, Thalhammer F, Schwameis E, Breyer S, Kotz R. Teicoplanin in the prevention of infection in total hip replacement. Arch Orthop Trauma Surg 1998;118:32-6.
2. Zimmerli W, Trampuz A, Ochsner P. Prosthetic-joint infections. N Engl J Med 2004;351:1645-54.
3. Gamer J. Guideline for prevention of surgical wound infections. http://wonder.cdc.gov/wonder/prevguid/p0000420/p0000420.asp (date last accessed 27 October 2005).
4. Nathens AB, Delinger EP. Surgical site infections. Curr Treat Options Infect Dis 2000;2:347-58.
5. Konig DP, Schierholz JM, Miinnich U, Riitt J. Treatment of staphylococcal implant infection with rifampicin-ciprofloxacin in stable implants. Arch Orthop Trauma Surg 2001;121:297-9.
6. Glenny A, Song F. Antimicrobial prophylaxis in total hip replacement: a systematic review. Health Technol Assess 1999;3:1-57.
7. No authors listed. Cochrane Library, Issue 2 2006. http://www.news.cochrane.org/view/item/review_one.jsp?j=603 (date last accessed 27 May 2008).
8. No authors listed. OVID MEDLINE, 1966 to July 2007. http://ovidsp.uk.ovid.com/spb/ovidweb.cgi?New+Database=Single/13&S= BFHBPDIEC0HF0OIEFNHLAHIHHPPAA00 (date last accessed 25 April 2008).
9. No authors listed. OVID EMBASE, 1980 to 2006 week 23. http://ovidsp.tx.ovid.com/spb/ovidweb.cgi?New+Database=Single/12&S=JGPMFPGE (date last accessed 25 April 2008).
10. No authors listed. Cumulative Index to Nursing and Allied Health Literature (CINAHL). http://ovidsp.uk.ovid.com/spb/ovidweb.cgi?New+Database= Single/8&S=BFHBPDIEC (date last accessed 25 April 2008).
11. No authors listed. Google Scholar, http://scholar.google.co.uk (date last accessed 27 May 2008).
12. No authors listed. AMEDE0. http://www.amedeo.com/ (date last accessed 27 May 2008).
13. Verhagen AP, De Vet HC, de Bie RA, et al. The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus. J Clin Epidemiol 1998;51:1235-41.
14. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719-48.
15. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539-58.
16. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
17. deLalla F, Viola R, Pellizer G, et al. Regional prophylaxis with teicoplanin in mon-olateral or bilateral total knee replacement: an open study. Antimicrob Agents Chemother 2000;44:316-19.
18. Nelson CL, Green TG, Porter RA, Warren RD. One day versus seven days of preventive antibiotic therapy in orthopedic surgery. Clin Orthop 1983;176:258-63.
19. Heydemann JS, Nelson CL. Short-term preventive antibiotics. Clin Orthop 1986;205:184-7.
20. Wymenga B, Hekster YA, Theeuwes A, et al. Antibiotic use after cefuroxime prophylaxis in hip and knee joint replacement. Clin Pharmacol Ther 1991;50:215-20.
21. Wymenga A, Van Horn J, Theeuwes A, Muytjens H, Slooff T. Cefuroxime for prevention of postoperative coxitis: one versus three doses tested in a randomized multicenter study of 2,651 arthroplasties. Acta Orthop Scand 1992;63:19-24.
22. Ritter MA, Campbell E, Keating EM, Faris PM. Comparison of intraoperative versus 24 hour antibiotic prophylaxis in total joint replacement: a controlled prospective study. Orthop Rev 1989;18:694-6.
23. Johnson DP. Antibiotic prophylaxis with cefuroxime in arthroplasty of the knee. J Bone Joint Surg [Br] 1987;69-B:787-9.
24. Moher D, Cook DJ, Eastwood S, et al. Improving the quality of reports of metaanalyses of randomised controlled trials: the QUORUM statement: quality of reporting of meta-analyses. Lancet 1999;354:1896-900.
25. Ritter M, Conway M, Stringer E, Williams J. Cephalosporin for total hip replacement. Orthopedics 1983;6:850-5.
26. DeBenedictis KJ, Rowan NM, Boyer BL. A double-blind study comparing cefonicid with cefazolin as prophylaxis in patients undergoing total hip or knee replacement. Rev Infect Dis 1984;6:901-4.
27. Mauerhan DR, Nelson CL, Smith DL, et al. Prophylaxis against infection in total joint arthroplasty: one day of cefuroxime compared with three days of cefazolin. J Bone Joint Surg [Am] 1994;76-A:39-45.
28. Periti P, Stringa G, Donati L, et al. Teicoplanin: its role as systemic therapy of burn infections and as prophylaxis for orthopaedic surgery: Italian Study Groups for Antimicrobial prophylaxis in orthopaedic surgery and burns. Eur J Surg 1992;567(Suppl):3-8.
29. Soave R, Hirsch JC, Salvati EA, Brause BD, Roberts RB. Comparison of cefora-nide and cephalothin prophylaxis in patients undergoing total joint arthroplasty. Orthopedics 1986;9:1657-60.
30. Davis WA, Kane JG. Antimicrobial prophylaxis for arthroplasty: a comparative study of cefonicid and cefazolin. Orthopedics 1987;10:1405-9.
31. Jones RN, Slepack JM, Wojeski WV. Cefotaxime single-dose surgical prophylaxis in a prepaid group practice: comparisons with other cephalosporins and ticarcillin/clavulanic acid. Drugs 1988;35:116-23.
32. Chiu FY, Chen CM, Lin CF, Lo WH. Cefuroxime-impregnated cement in primary total knee arthroplasty: a prospective, randomized study of three hundred and forty knees. J Bone Joint Surg [Am] 2002;84-A:759-62.
33. Chiu FY, Lin CF, Chen CM, Lo WH, Chaung T-Y. Cefuroxime- impregnated cement at primary total knee arthroplasty in diabetes mellitus: a prospective, randomised study. J Bone Joint Surg [Br] 2001;83-B:691-5.
34. Carlsson AS, Lidgren L, Lindberg L. Prophylactic antibiotics against early and late deep infections after total hip replacements. Acta Orthop Scand 1977;48:405-10.
35. Davies AJ, Lockley RM, Jones A, el-Safty M, Clotheir JC. Comparative pharmo-cokinetics of cefamandole, cefuroxime and cephradine during total hip replacement. J Antimicrob Chemother 1986;17:637-40.
36. Doyon F, Evrard J, Mazas F, Hill C. Long-term results of prophylactic cefaxolin versus placebo in total hip replacement. Lancet 1987;1:860.
37. Evrard J, Doyon F, Acar JF, et al. Two-day cefamandole versus five-day cephazolin prophylaxis in 965 total hip replacements: report of a multicentre double blind randomised trial. Int Orthop 1988;12:69-73.
38. Gunst JP, Deletang S, Rogez MJ, et al. Prophylactic antibiotic therapy by cefamandole in total hip surgery replacement using Chamley's tent: a randomized study. Pathol Biol (Paris) 1984;32:567-9 (in French).
39. Josefsson G, Kolmert L. Prophylaxis with systematic antibiotic versus gentamicin bone cement in total hip arthroplasty. Clin Orthop 1993;292:210-14.
40. Pollard JP, Hughes SP, Scott JE, Evans MJ, Benson MKD. Antibiotic prophylaxis in total hip replacement. BMJ 1979;1:707-9.
41. Schulitz KP, Winkelman W, Schoening B. The prophylactic use of antibiotics on alloarthroplasty of the hip joint for coxarthrosis. Arch Orthop Trauma Surg 1980;96:79-82.
42. Suter F, Avai A, Fusco U, et al. Teicoplanin versus cefamandole in the prevention of infection in total hip replacement. Eur J Clin Microbiol Infect Dis 1994;13:793-6.
43. Wollinsky KH, Oethinger M, Biichele M, et al. Autotransfusion: bacterial contamination during hip arthroplasty and efficacy of cefuroxime prophylaxis: a randomized controlled study of 40 patients. Acta Orthop Scand 1997;68:225-30.
44. McQueen M, Littlejohn A, Hughes SP. A comparison of systemic cefuroxime and cefuroxime loaded bone cement in the prevention of early infection after total joint replacement. Int Orthop 1987;11:241-3.
45. McOueen MM, Hughes SP, May P, Verity L. Cefuroxime in total joint arthroplasty: intravenous or in bone cement. J Arthroplasty 1990;5:169-72.
46. Mollan RA, Haddock M, Webb CH. Teicoplanin vs cephamandole for antimicrobial prophylaxis in prosthetic joint implant surgery: preliminary results. Eur J Surg 1992;567(Suppl):19-21.
47. Periti P, Stringa G, Mini E. Comparative multicenter trial of teicoplanin versus cefazolin for antimicrobial prophylaxis in prosthetic joint implant surgery: Italian Study Group for Antimicrobial prophylaxis in orthopaedic surgery. Eur J Clin Microbial Infecf Dis 1999;18:113-19.
48. Vainionpaa S, Wilppula E, Lalla M, Renkonen OV, Rokkanen P. Cefamandole and isoxazolyl penicillins in antibiotic prophylaxis of patients undergoing total hip or knee-joint arthroplasty. Arch Orthop Trauma Surg 1988;107:228-30.
49. Wall R, Klenerman L, McCullough C, Fyfe I. A comparison of teicoplanin and cefuroxime as prophylaxis for orthopaedic implant surgery: a preliminary report. J Antimicrob Chemother 1988;21:141-6.
50. Bryan CS, Morgan SL, Caton RJ, Lunceford EM Jr. Cefazolin versus cefamandole for prophylaxis during total joint arthroplasty. Clin Orthop 1988;228:117-22.
51. Ericson C, Lidgren L, Lindberg L. Cloxacillin in the prophylaxis of postoperative infections of the hip. J Bone Joint Surg [Am] 1973;55-A:803-13.
52. Hill C, Flamant R, Mazas F, Evrard J. Prophylactic cefazolin versus placebo in total hip replacement: report of a multicentre double-blind randomised trial. Lancet 1981;1:795-6.
53. Jones RN, Wojeski WV. Single-dose surgical prophylaxis using ticarcillin/clauvulanic acid (Timentin): a prospective, randomised comparison with fecotaxime. Diagn Microbiol Infect Dis 1987;7:219-23.
54. Egger M, Zellwager-Zähner T, Schneider M, et al. Language bias in randomised controlled trials published in English and German. Lancet 1997;350:326-9.
55. No authors listed. Consort Group. http://www.consort-statement. org/ (date last accessed 5 October 2006).
56. Ouenon JL, Eveillard M, Vivien A, et al. Evaluation of current practices in surgical antimicrobial prophylaxis in primary total hip prosthesis: a multicentre survey in private and public French hospitals. J Hosp Infect 2004;56:202-7.
57. Bratzler DW, Houck PM, Richards C, et al. Use of antimicrobial prophylaxis for major surgery: baseline results from the National Surgical Infection Prevention Project. Arch Surg 2005;140:174-82.
58. Graves N, Halton K, Lairson D. Economics and preventing hospital-acquired infection: broadening the perspective. Infect Control Hosp Epidemiol 2007;28:178-84.